Transcenta Announces Updated Board Composition and Committee Structure

Bulletin Express
06/30

Transcenta Holding Limited released an updated list of directors and their respective committee roles, confirming the governance framework in place as of 30 June 2026.

Executive Leadership • Dr. Xueming Qian serves as Chief Executive Officer, Chairman of the Board, and Chairperson of the Nomination Committee.

Non-Executive Directors • Dr. Li Xu • Dr. Hansen Xu

Independent Non-Executive Directors • Mr. Jiasong Tang • Ms. Helen Wei Chen

Board Committee Assignments 1. Audit Committee – Chairperson: Mr. Jiasong Tang – Members: Dr. Li Xu and Dr. Hansen Xu

2. Remuneration Committee – Chairperson: Ms. Helen Wei Chen – Members: Dr. Li Xu and Dr. Hansen Xu

3. Nomination Committee – Chairperson: Dr. Xueming Qian – Members: Mr. Jiasong Tang and Ms. Helen Wei Chen

The announcement confirms that all three committees—Audit, Remuneration and Nomination—are chaired by independent directors or the Chairman of the Board, reflecting adherence to corporate governance best practices. The Board composition comprises one executive director, two non-executive directors and two independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10